3SBio develops, manufactures, and sells biologic medicines, mainly in China. Its best-known drugs raise low platelet counts (TPIAO) and treat anemia (EPIAO). It also sells treatments for autoimmune diseases, HER2-positive breast cancer, and hair loss.

Healthcare · Biotechnology · 1530.HK

What 3SBio Does & How It Makes Money (1530.HK)

Updated October 2026 · reflects 3SBio's latest reported financials

Chinese biopharma company making blood, immunology, and cancer biologic drugs. It earns revenue mainly by selling its marketed biopharmaceutical drugs to hospitals and patients in China and abroad.

3SBio's story, moat and numbers — in a 3-minute visual book.

Explore 3SBio on TacticScale →

How 3SBio makes money

It earns revenue mainly by selling its marketed biopharmaceutical drugs to hospitals and patients in China and abroad. It is also building a pipeline of antibody drugs for future sales, and it has smaller income from pharmaceutical retail and various service businesses.

What 3SBio does

3SBio Inc., founded in 1993 and headquartered in Shenyang, is a Chinese biopharmaceutical company that develops, manufactures, and markets biologic drugs in China, the United States, and other markets. Its core franchise is in blood-related conditions: TPIAO treats several forms of thrombocytopenia (low platelets), including chemotherapy-induced, immune, pediatric, and chronic liver disease-related cases. EPIAO treats anemia linked to chronic kidney disease and chemotherapy, and is also used to reduce the need for blood transfusions during surgery. Beyond hematology, it sells Yisaipu (a TNF-α inhibitor for rheumatoid arthritis, ankylosing spondylitis, and psoriasis), Cipterbin (an anti-HER2 antibody for metastatic breast cancer), and Mandi (a minoxidil tincture for hair loss). Its pipeline centers on antibodies and follow-on hematology products. These include 608 (anti-IL-17A), 611 (anti-IL-4Rα), 601A (anti-VEGF), 613 for acute gouty arthritis, SSS20 for ITP and severe aplastic anemia, and SSS06, a biweekly-dosed option for dialysis patients. The group also has smaller activities in pharmaceutical retail, consulting, and assorted technical, financial, and clinic services.

Products & services

TPIAO (thrombocytopenia)
EPIAO (anemia)
Yisaipu (TNF-α inhibitor)
Cipterbin (anti-HER2 mAb)
Mandi (minoxidil tincture)
608 anti-IL-17A mAb (pipeline)

What is 3SBio worth?

Fair value: not published

A reliable owner-earnings fair value isn't available for this company yet — we'd rather say so than print a number we don't trust.

We show a fair value only when the method is trustworthy. See 3SBio on TacticScale →

Sector Healthcare Industry Biotechnology HQ China Ticker 1530.HK Official site

Related companies

Bio-Thera Solutions (688177.SS) · Sino Biological,Inc (301047.SZ) · Pacific Shuanglin Bio-pharmacy (000403.SZ)

Understand 3SBio in 3 minutes →